Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $8.5569 per ML under NDC 82260063010. Its NADAC has been published 86 times since Nov 6, 2024.
Strength
15 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260063010
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BEPOTASTINE BESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022288On Market Since
5/28/2021
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 86 times since Nov 6, 2024, and over the history we have for it it has declined 46.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.5569 per ML |
|---|---|
| All-time high | $17.6086 (Jul 16, 2025) |
| All-time low | $8.5569 (Jun 17, 2026) |
| 52-week high | $17.6086 |
| 52-week low | $8.5569 |
| Median price | $16.0979 |
| Average price | $15.1063 |
| Largest weekly change | -17.7% (May 20, 2026) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Bausch & Lomb Americas Inc., is $8.5569 per ML (NDC 82260063010), effective Jun 24, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 46.7%. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Nov 6, 2024, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $8.5569 (Jun 17, 2026) to a high of $17.6086 (Jul 16, 2025), with a median of $16.0979 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BEPOTASTINE 1.5% EYE DROP, but none are currently priced below it.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 82260063010) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification